Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension
Yi-Yin Tai,Qiujun Yu,Ying Tang,Wei Sun,Neil J. Kelly,Satoshi Okawa,Jingsi Zhao,Tae-Hwi Schwantes-An,Caroline Lacoux,Stephanie Torrino,Yassmin Al Aaraj,Wadih El Khoury,Vinny Negi,Mingjun Liu,Catherine G. Corey,Frances Belmonte,Sara O. Vargas,Brian Schwartz,Bal Bhat,B. Nelson Chau,Jason H. Karnes,Taijyu Satoh,Robert J. Barndt,Haodi Wu,Victoria N. Parikh,Jianrong Wang,Yingze Zhang,Dennis McNamara,Gang Li,Gil Speyer,Bing Wang,Sruti Shiva,Brett Kaufman,Seungchan Kim,Delphine Gomez,Bernard Mari,Michael H. Cho,Adel Boueiz,Michael W. Pauciulo,Laura Southgate,Richard C. Trembath,Olivier Sitbon,Marc Humbert,Stefan Graf,Nicholas W. Morrell,Christopher J. Rhodes,Martin R. Wilkins,Mehdi Nouraie,William C. Nichols,Ankit A. Desai,Thomas Bertero,Stephen Y. Chan
DOI: https://doi.org/10.1126/scitranslmed.add2029
IF: 17.1
2024-01-11
Science Translational Medicine
Abstract:Hypoxic reprogramming of vasculature relies on genetic, epigenetic, and metabolic circuitry, but the control points are unknown. In pulmonary arterial hypertension (PAH), a disease driven by hypoxia inducible factor (HIF)–dependent vascular dysfunction, HIF-2α promoted expression of neighboring genes, long noncoding RNA (lncRNA) histone lysine N -methyltransferase 2E-antisense 1 ( KMT2E-AS1 ) and histone lysine N-methyltransferase 2E ( KMT2E ). KMT2E-AS1 stabilized KMT2E protein to increase epigenetic histone 3 lysine 4 trimethylation (H3K4me3), driving HIF-2α–dependent metabolic and pathogenic endothelial activity. This lncRNA axis also increased HIF-2α expression across epigenetic, transcriptional, and posttranscriptional contexts, thus promoting a positive feedback loop to further augment HIF-2α activity. We identified a genetic association between rs73184087, a single-nucleotide variant (SNV) within a KMT2E intron, and disease risk in PAH discovery and replication patient cohorts and in a global meta-analysis. This SNV displayed allele (G)–specific association with HIF-2α, engaged in long-range chromatin interactions, and induced the lncRNA-KMT2E tandem in hypoxic (G/G) cells. In vivo, KMT2E-AS1 deficiency protected against PAH in mice, as did pharmacologic inhibition of histone methylation in rats. Conversely, forced lncRNA expression promoted more severe PH. Thus, the KMT2E-AS1 /KMT2E pair orchestrates across convergent multi-ome landscapes to mediate HIF-2α pathobiology and represents a key clinical target in pulmonary hypertension.
cell biology,medicine, research & experimental
What problem does this paper attempt to address?
### The Problem the Paper Attempts to Solve
This paper aims to explore the mechanism of long non-coding RNA (lncRNA) KMT2E-AS1 in pulmonary arterial hypertension (PAH). Specifically, the researchers attempt to answer the following questions:
1. **How does KMT2E-AS1 regulate the pathological changes of pulmonary vascular endothelial cells under hypoxic conditions?**
- The study found that KMT2E-AS1 stabilizes the KMT2E protein, increases the trimethylation of histone H3K4me3, thereby promoting hypoxia-inducible factor HIF-2α-dependent metabolic and pathological activities.
2. **How does the interaction between KMT2E-AS1 and KMT2E affect the development of PAH?**
- The research shows that KMT2E-AS1 and KMT2E form a positive feedback loop, further enhancing the activity of HIF-2α, thereby exacerbating the pathological process of PAH.
3. **Is the specific single nucleotide variant (SNV) rs73184087 associated with the risk of PAH?**
- Through genetic association analysis, the researchers found that rs73184087 is significantly associated with the risk of PAH, and this variant can induce the expression of KMT2E-AS1 and KMT2E under hypoxic conditions.
4. **What is the impact of KMT2E-AS1 on PAH in vivo and in vitro?**
- In mouse and rat models, the lack of KMT2E-AS1 or drugs that inhibit histone methylation can protect animals from PAH. Conversely, forced expression of KMT2E-AS1 exacerbates the condition of PAH.
Through these studies, the paper reveals the critical role of the KMT2E-AS1/KMT2E axis in PAH, providing a theoretical basis for developing new therapeutic strategies.